Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae - extensive acute proximal deep vein thrombosis - acute massive pulmonary embolism - acute occlusive peripheral arterial disease with limb threatening ischemia
Tuberculosis remains a global health problem, with an estimated 10.4 million cases and 1.8 million deaths resulting from the disease in 2015. The most lethal and disabling form of tuberculosis is tuberculous meningitis...
For all forms of pulmonary and extra-pulmonary tuberculosis.
Key findings from the largest global public survey to be undertaken on awareness and attitudes about lupus are set to be announced this World Lupus Day, 10th May 2017.